Alnylam Pharmaceuticals Inc (ALNY)
267.99
-1.54
(-0.57%)
USD |
NASDAQ |
Oct 04, 16:00
267.99
0.00 (0.00%)
After-Hours: 20:00
Alnylam Pharmaceuticals Shareholders Equity (Annual): -220.64M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -220.64M |
| December 31, 2022 | -158.22M |
| December 31, 2021 | 588.20M |
| December 31, 2020 | 1.016B |
| December 31, 2019 | 1.439B |
| December 31, 2018 | 1.302B |
| December 31, 2017 | 1.766B |
| December 31, 2016 | 920.22M |
| December 31, 2015 | 1.265B |
| December 31, 2014 | 936.27M |
| December 31, 2013 | 270.35M |
| Date | Value |
|---|---|
| December 31, 2012 | 134.05M |
| December 31, 2011 | 118.00M |
| December 31, 2010 | 158.23M |
| December 31, 2009 | 177.96M |
| December 31, 2008 | 202.12M |
| December 31, 2007 | 199.17M |
| December 31, 2006 | 201.17M |
| December 31, 2005 | 61.78M |
| December 31, 2004 | 46.14M |
| December 31, 2003 | -26.71M |
| December 31, 2002 | -4.646M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-220.64M
Minimum
2023
1.439B
Maximum
2019
532.86M
Average
588.20M
Median
2021
Shareholders Equity (Annual) Benchmarks
| Pfizer Inc | 89.01B |
| Biomarin Pharmaceutical Inc | 4.952B |
| Regeneron Pharmaceuticals Inc | 25.97B |
| BridgeBio Pharma Inc | -1.354B |
| Ionis Pharmaceuticals Inc | 386.69M |